These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27486530)

  • 41. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
    Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
    Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19.
    Jiang P; Wu SH; Zhu T; Guo Y; He Y
    J Med Virol; 2022 Apr; 94(4):1745-1747. PubMed ID: 34911144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypokalemia and muscle paralysis after low-dose methylprednisolone.
    Büyükcam F; Calık M; Erkuran MK; Akay H
    Am J Emerg Med; 2011 Jun; 29(5):573.e1-2. PubMed ID: 20685057
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sinus bradycardia secondary to the use of pulse corticosteroids].
    Domínguez-Pinilla N; Del Fresno-Valencia MR; de Inocencio Arocena J; Enríquez Merayo E
    An Pediatr (Barc); 2014 May; 80(5):331-2. PubMed ID: 24280428
    [No Abstract]   [Full Text] [Related]  

  • 45. Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
    Cohen JA; Calabresi PA; Chakraborty S; Edwards KR; Eickenhorst T; Felton WL; Fisher E; Fox RJ; Goodman AD; Hara-Cleaver C; Hutton GJ; Imrey PB; Ivancic DM; Mandell BF; Perryman JE; Scott TF; Skaramagas TT; Zhang H;
    Mult Scler; 2008 Apr; 14(3):370-82. PubMed ID: 18208877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis.
    Zorzon M; Zivadinov R; Locatelli L; Giuntini D; Toncic M; Bosco A; Nasuelli D; Bratina A; Tommasi MA; Rudick RA; Cazzato G
    Eur J Neurol; 2005 Jul; 12(7):550-6. PubMed ID: 15958096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.
    Vasheghani-Farahani A; Sahraian MA; Darabi L; Aghsaie A; Minagar A
    J Neurol Sci; 2011 Oct; 309(1-2):75-8. PubMed ID: 21831398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid-induced avascular necrosis.
    Clinkscales A; Cleary JD
    Ann Pharmacother; 2002 Jun; 36(6):1105. PubMed ID: 12058706
    [No Abstract]   [Full Text] [Related]  

  • 50. Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance.
    Blair NF; Brew BJ; Halpern JP
    Neurology; 2012 Feb; 78(7):507-8. PubMed ID: 22302545
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypotension, bradycardia, and asystole after high-dose intravenous methylprednisolone in a monitored patient.
    Guillén EL; Ruíz AM; Bugallo JB
    Am J Kidney Dis; 1998 Jul; 32(2):E4. PubMed ID: 10074612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis.
    Oliveri RL; Sibilia G; Valentino P; Russo C; Romeo N; Quattrone A
    Acta Neurol Scand; 1998 Jun; 97(6):366-9. PubMed ID: 9669468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A balancing act--making the right choices in anti-inflammatory drug development.
    Elices MJ
    Curr Opin Investig Drugs; 2007 May; 8(5):362-3. PubMed ID: 17520864
    [No Abstract]   [Full Text] [Related]  

  • 54. Intrathecal methylprednisolone for postherpetic neuralgia.
    Nelson DA; Landau WM
    N Engl J Med; 2001 Mar; 344(13):1019; author reply 1021-2. PubMed ID: 11280320
    [No Abstract]   [Full Text] [Related]  

  • 55. Intrathecal methylprednisolone for postherpetic neuralgia.
    Lampe JB; Hindinger C; Reichmann H
    N Engl J Med; 2001 Mar; 344(13):1019-20; author reply 1021-2. PubMed ID: 11280319
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy.
    Bartalena L; Krassas GE; Wiersinga W; Marcocci C; Salvi M; Daumerie C; Bournaud C; Stahl M; Sassi L; Veronesi G; Azzolini C; Boboridis KG; Mourits MP; Soeters MR; Baldeschi L; Nardi M; Currò N; Boschi A; Bernard M; von Arx G;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4454-63. PubMed ID: 23038682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 6-Methylprednisolone-induced bronchospasm.
    Fernández S; Reaño M; Vives R; Borja J; Daroca P; Canto G; Rodríguez J
    Allergy; 1997 Jul; 52(7):780-2. PubMed ID: 9265999
    [No Abstract]   [Full Text] [Related]  

  • 58. Anaphylactoid reaction to intravenous methylprednisolone in a patient with multiple sclerosis.
    van den Berg JS; van Eikema Hommes OR; Wuis EW; Stapel S; van der Valk PG
    J Neurol Neurosurg Psychiatry; 1997 Dec; 63(6):813-4. PubMed ID: 9416829
    [No Abstract]   [Full Text] [Related]  

  • 59. Oral corticosteroids for multiple sclerosis relapse.
    Comi G; Radaelli M
    Lancet; 2015 Sep; 386(9997):937-9. PubMed ID: 26369452
    [No Abstract]   [Full Text] [Related]  

  • 60. Marked bradycardia due to pulsed and oral methylprednisolone therapy in a patient with rapidly progressive glomerulonephritis.
    Küçükosmanoğlu O; Karabay A; Ozbarlas N; Noyan A; Anarat A
    Nephron; 1998 Dec; 80(4):484. PubMed ID: 9832654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.